GLP-1 Analogues Market Seen Soaring ~28% Growth to Reach USD Billion by 2032, Projects UnivDatos

Key Highlights of the Report:

• Rising Prevalence of Type 2 Diabetes and Obesity: The global novel cases of type 2 diabetes and obesity are pivotal to the surging demand for GLP-1 analogues. These drugs are effective for controlling blood sugar and help in the process of weight loss and for this reason, they are preferred most of the time. It contributes to the calmer for such therapies because people are living longer, and they have unhealthy lifestyles.

• Technological Advancements in Drug Delivery: Newer oral GLP-1 analogues and developments in long-acting preparations promote patient compliance. These advancements solve the problem areas that were previously tagged to injectable drugs thereby extending the range of the users. New approaches at the furthest development point involve firms seeking to produce better and more convenient ways of delivery.

• Expanding Indications Beyond Diabetes: GLP-1 analogues are already used for weight loss and cardiovascular disease risk mitigation. This expansion of indications enable major management companies to cover a larger patient base. This coupled need to manage diabetes and obesity is actually propelling more people to adopt it worldwide.

According to a new report by UnivDatos, The GLP-1 Analogues Market is expected to reach USD Billion in 2032 by growing at a CAGR of 28%. This is mainly due to the increase in the global prevalence of type 2 diabetes and obesity, the growing need for weight management solutions, and the broadening of cardiovascular efficacy profile. The availability of new methods of drug delivery, especially including oral preparations and the development of long-acting analogues also increases the adoption of the drug. Furthermore, increased patient awareness levels and government promotion related to diabetes improve market access.

On June 12, 2023, Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that new findings for efinopegdutide (MK-6024), an investigational GLP-1/glucagon receptor co-agonist, have been accepted for oral presentation at the European Association for the Study of the Liver (EASL) Annual Congress from June 21-24.

Segments that transform the industry

• Based on application, the market is segmented into type 2 diabetes and weight loss. Type 2 diabetes held a significant share of the market in 2023. The increasing global incidence of type 2 diabetes leads to the need for more GLP-1 analogues such as liraglutide that help to manage blood sugar levels while promoting weight loss. Such drugs are progressively preferred with respect to conventional treatments for their multiple valued aspects. Moreover, companies are improving access by expanding into growth lots and partnering with healthcare facilities exerting pressure for early detection.

According to the report, the impact of GLP-1 Analogues has been identified to be high for the Asia-Pacific area. Some of how this impact has been felt include:

Asia-Pacific is expected to grow with a significant CAGR during the forecast period (2024-2032). This is because of a growing incidence of diabetes, the growth of cities, and, lastly, the increase in health care costs. Adding to this, the increased concerns among people regarding proper diabetes management drive the growth of superior diabetes management solutions in key areas such as China, India, and Japan. Moreover, companies pay much attention to growing the coverage through mergers, acquisitions, joint ventures, and own production facilities as well as localized advertisement techniques. More importantly, the approval of regulators and the availability of low-cost products are essential for new markets. Further, the concerned e-health technologies and telemedicine are helping the healthcare unit inpatient reach and compliance in rural areas.

Key Offerings of the Report

Market Size, Trends, & Forecast by Revenue | 2024−2032.

Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities

Market Segmentation – A detailed analysis By Indication, By Application, By Distribution Channel, By Region/Country

Competitive Landscape – Top Key Vendors and Other Prominent Vendors